Buyer = Biogen = soon

Discussion in 'Acorda Therapeutics' started by anonymous, Jan 19, 2018 at 7:44 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    You cant be serious. Most industry insiders rely on Glassdoor for an insider's assessment of a company. These are objective ratings. That we do so well is a testament to the superior leadership, benefits and work-life balance that we enjoy. Sure there have been some mistakes however I venture to claim that if a moron intern didn't screw up we would already have had that FDA approval. I guess thats on us for not properly overseeing the work product filing.
     

  2. anonymous

    anonymous Guest

    No insiders rely on Glassdoor you twit. That site is used by admins and low level staff who have no one on the inside or the industry to give them the real story. I believe you like to call them the “rank and file”.

    That ACOR does well is indicative of the continued amateurish PR campaign RC pays for via H1B labor to keep his image up.
     
  3. anonymous

    anonymous Guest

    Glassdoor, Gallstone - whatever

    It makes no difference because Acorda is a fantastic company being led by smart and caring people. Ron and Lauren are both amazing and much deserve our admiration.

    Go Acorda!!!!
     
  4. anonymous

    anonymous Guest

    You need to be educated. Glassdoor is the de-facto standard used by industry professionals to get an honest assessment of a company. FROM INSIDERS WHO WORK WITHIN THE COMPANY!!! The correlation between Glassdoor rankings and other rankings is indeed very strong. These are honest ratings that come from rank and file as well as from the Leadership!! Read many of the voluntary comments and you will see praise of our Leaders !
     
  5. anonymous

    anonymous Guest

    Well I guess I stand corrected. Since your opinion dwarfs reality in so many instances.

    Congrats on the back to back posts, which is indicative of your PR campaign on Glassdoor as well.

    Given that the only “insiders” you know are the ones who pay you to post, I wouldn’t expect you to know the real view of Acorda’s prospects or reputation from the outside.

    Your current state is not the result of cutting edge science or visionary leadership, but the result of narcissism, incompetence and nepotism.

    But I will defer to your “reviews” on Glassdoor.
     
  6. anonymous

    anonymous Guest

    Can someone post the link to this Acorda's Glassdoor site?
    (Investor that wants to review it)
     
  7. anonymous

    anonymous Guest

    Thank you. It takes a big person to admit they were wrong. Also note that Ron's rating has now reached 92% ! This is in the stratosphere for a Glassdoor rating.
     
  8. anonymous

    anonymous Guest

    that's a remarkable favorability statistic, being that there is no way for anyone to vote twice (cheat). He must have a yuge fanclub,
     
  9. anonymous

    anonymous Guest

    lucky to have him
     
  10. anonymous

    anonymous Guest

    Ron is utterly amazing

    He should run for President and teach Trump a lesson or two on how to run effectively a country

    I will vote for Ron - once and maybe twice if I can get away with it

    ;-)

    Go Ron!!!
    Go ACORDA!!!!!
     
  11. anonymous

    anonymous Guest

    his wife would be an awesome first lady, being a model and former USA beauty contestant
     
  12. anonymous

    anonymous Guest

    ACOR already up 3.7% this morning. This appears to be the beginning of a major run up. TIME TO BUY ACOR NOW !!!!!!!!!!!!!!!!!!!!!!!!!!
     
  13. anonymous

    anonymous Guest


    Up another 1% at close, so that's almost 5% in TWO DAYS !!!!!! I made a cool 122K on day trading this gem !! Beats being a shelf stocker field rep !!
    I love Ron, he is a master guru and will defend him frum the idiotic posts...
     
  14. anonymous

    anonymous Guest

    when is acor Buy out Done
     
  15. anonymous

    anonymous Guest

    ---------------- TRUST RON IN 2018 ! -----------------_______________
     
  16. anonymous

    anonymous Guest

    Wish i could be in your boat.

    When i started, my stock price was $35.22 for 1000 shares. Therefore, not going to see any gain as much as I would have loved to. Even if the stock hits $40, I would only make $4,780 :-( when I sell
     
  17. anonymous

    anonymous Guest

    Be patient my friend. Many financial pros see this stock rising to at least the mid 50's this year. Our CEO is working hard to maximize our equity wealth in ACOR. That's why so many love him.
     
  18. anonymous

    anonymous Guest

    Fartbag? Not bad! One question: Why do fuckheads like you add a space before punctuation? Jesus Christ, that drives me crazy.
     
  19. anonymous

    anonymous Guest

    Are you idiots still believing the BS leadership?
    EVERY good person ha left!
    You are staying around for what? Morons!
    Have they not told you that behind closed doors offers are being entertained?
    Hence why the severance was upped. You people are fools! B players.
     
  20. anonymous

    anonymous Guest

    There’s no driver for a buyout.... all spin from internal maouthpiece to the street. We could not even execute a lifecycle plan for LOE on Ampyra, how many patents shot down and hanging on a string. Stock based comp annualized At >$22M ??? Someone’s approving massive equity in advance of a buyout? Questionable practice at best. .....lucky to get a 10% premium over current price.... and if that happens take it and run before the buyer realizes the shit risk they just purchased.